[The study Peptide-ALPHA: a role of bladder regulatory peptides and alpha-blockers in combination therapy for LUTS].

The addition of Vesusten to alpha-blockers in patients with LUTS and OAB caused by BPH significantly reduced irritative symptoms according to questionnaires, uroflowmetry and postvoid residual volume. Only mild local AEs were observed that did not require discontinuation of therapy.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-03-01
Primary Topic
Eicosanoids and Hypertension Pharmacology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[The study Peptide-ALPHA: a role of bladder regulatory peptides and alpha-blockers in combination therapy for LUTS].

G Spivak L, Ruchitha Reddy S., Oda A
PubMed
Eicosanoids and Hypertension Pharmacology
article

[The study Peptide-ALPHA: a role of bladder regulatory peptides and alpha-blockers in combination therapy for LUTS].

G Spivak L, Ruchitha Reddy S., Oda A
article en

Abstract

The addition of Vesusten to alpha-blockers in patients with LUTS and OAB caused by BPH significantly reduced irritative symptoms according to questionnaires, uroflowmetry and postvoid residual volume. Only mild local AEs were observed that did not require discontinuation of therapy.

PubMed(1)
Sechenov University (RU), Research Institute of Emergency Care (RU)
Openalex Percentile: Top 89%
Eicosanoids and Hypertension Pharmacology
OpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

[The study Peptide-ALPHA: a role of bladder regulatory peptides and alpha-blockers in combination therapy for LUTS]. — G Spivak L, Ruchitha Reddy S., et al. · PubMed (2025) | TGRS Research Map | TGRS